Clinical Conversations (CE): GLP Practice Insights: GLP-1 Receptor Agonists and Neurodegenerative Disorders (CE)

This session discusses the potential sites of action and benefits for GLP-1 agonists (GLP-1a) in the pathology of two neurodegenerative disorders, Alzheimer’s Disease (AD) and Parkinson’s Disease (PD). This session will also review the published and pending clinical literature of FDA approved GLP-1a use in AD and PD. The information presented during the podcast reflects solely the opinions of the…